BGB-3111_GA101_Study_001
Completed
BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies
BeOne Study ID 
BGB-3111_GA101_Study_001
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / N/A
Study Documents
Study Protocol Statistical Analysis PlanStudy Overview
Sex:
All
Age: 18 Years / N/A